is microdosing glp 1 safer GLP-1 Safe? Everything You Need to Know How microdosing GLP-1 drugs became

Until now the tests with exendin-4 had only been done in mice and the company was unsure what would happen when it was given to humans

From this it appeared to Holst that something had changed in their gut that altered its metabolism

Featured Snippet Answer : Based on current Phase 2 clinical trial data, Retatrutide achieved approximately 24% body weight reduction in 48 weeks, compared to semaglutides ~15% and tirzepatides ~22%

this should be considered by clinicians in any trial or supervised setting, in line with NICE guideline NG28 (Type 2 diabetes in adults)

Comment on Kom et al

You can reach out to our dedicated support team via the contact form on our website